APA (7th ed.) Citation

Young, C. S., Clarke, K. M., Kettyle, L. M., Thompson, A., & Mills, K. I. (2017). Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy. Impact Journals.

Chicago Style (17th ed.) Citation

Young, Christine S., Kathryn M. Clarke, Laura M. Kettyle, Alexander Thompson, and Ken I. Mills. Decitabine-Vorinostat Combination Treatment in Acute Myeloid Leukemia Activates Pathways with Potential for Novel Triple Therapy. Impact Journals, 2017.

MLA (9th ed.) Citation

Young, Christine S., et al. Decitabine-Vorinostat Combination Treatment in Acute Myeloid Leukemia Activates Pathways with Potential for Novel Triple Therapy. Impact Journals, 2017.